<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en-US">
	<id>https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_C_funding</id>
	<title>Definition:Series C funding - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.insurerbrain.com/w/index.php?action=history&amp;feed=atom&amp;title=Definition%3ASeries_C_funding"/>
	<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_C_funding&amp;action=history"/>
	<updated>2026-04-30T17:16:14Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://www.insurerbrain.com/w/index.php?title=Definition:Series_C_funding&amp;diff=17065&amp;oldid=prev</id>
		<title>PlumBot: Bot: Creating new article from JSON</title>
		<link rel="alternate" type="text/html" href="https://www.insurerbrain.com/w/index.php?title=Definition:Series_C_funding&amp;diff=17065&amp;oldid=prev"/>
		<updated>2026-03-15T10:12:35Z</updated>

		<summary type="html">&lt;p&gt;Bot: Creating new article from JSON&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;💰 &amp;#039;&amp;#039;&amp;#039;Series C funding&amp;#039;&amp;#039;&amp;#039; is a later-stage [[Definition:Venture capital | venture capital]] financing round typically raised by [[Definition:Insurtech | insurtech]] companies and other insurance-sector startups that have already demonstrated product-market fit, meaningful [[Definition:Gross written premium (GWP) | premium]] volume or revenue, and a credible path toward profitability. By this stage, the company has usually progressed past early proof-of-concept ([[Definition:Series A funding | Series A]]) and scaling milestones ([[Definition:Series B funding | Series B]]), and is seeking capital to expand into new geographies, acquire complementary businesses, deepen carrier partnerships, or build the [[Definition:Reserving | reserve]] base needed to support growing [[Definition:Underwriting | underwriting]] portfolios.&lt;br /&gt;
&lt;br /&gt;
⚙️ Series C investors tend to be larger and more risk-averse than earlier-stage backers — the round frequently attracts growth equity firms, [[Definition:Private equity | private equity]] funds, corporate venture arms of major [[Definition:Insurance carrier | insurers]] or [[Definition:Reinsurer | reinsurers]], and crossover hedge funds that also invest in public markets. Valuations at Series C are scrutinized against more traditional insurance metrics: [[Definition:Loss ratio | loss ratios]], [[Definition:Combined ratio | combined ratios]], customer retention rates, and unit economics per policy, rather than the sheer growth multiples that may have sufficed in earlier rounds. The due diligence process often involves detailed reviews of [[Definition:Actuarial analysis | actuarial projections]], [[Definition:Claims management | claims management]] capabilities, regulatory licenses across target markets, and the durability of relationships with capacity providers. If the company is a [[Definition:Managing general agent (MGA) | MGA]] or [[Definition:Coverholder | coverholder]], investors will examine the terms and renewal prospects of [[Definition:Binding authority agreement | binding authority agreements]] as a proxy for revenue stability.&lt;br /&gt;
&lt;br /&gt;
🚀 Reaching a Series C round is a significant inflection point because it typically signals that a company is preparing for a final push toward self-sustaining economics — whether that culminates in an [[Definition:Initial public offering (IPO) | IPO]], a strategic acquisition, or long-term private ownership. In the insurtech landscape, several notable companies have used Series C capital to fund geographic expansion — moving, for example, from a single-country launch into multi-market operations across Europe or Asia-Pacific — or to transition from a technology-first model into a full-stack [[Definition:Insurance carrier | carrier]] holding its own regulatory licenses. The round also represents a moment of truth for investor expectations: companies unable to demonstrate [[Definition:Underwriting profit | underwriting discipline]] and improving economics at this stage may face a [[Definition:Down round | down round]] or struggle to attract further financing, underscoring the insurance industry&amp;#039;s ultimate demand that growth be paired with sustainable risk selection.&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;Related concepts:&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
{{Div col|colwidth=20em}}&lt;br /&gt;
* [[Definition:Series A funding]]&lt;br /&gt;
* [[Definition:Series B funding]]&lt;br /&gt;
* [[Definition:Venture capital]]&lt;br /&gt;
* [[Definition:Down round]]&lt;br /&gt;
* [[Definition:Insurtech]]&lt;br /&gt;
* [[Definition:Initial public offering (IPO)]]&lt;br /&gt;
{{Div col end}}&lt;/div&gt;</summary>
		<author><name>PlumBot</name></author>
	</entry>
</feed>